MEET CONGRESS 2015 - Tuesday June 9

Tuesday June 9

08.15	Carotid Occlusive Disease Are we ready for the next breakthrough?
	Moderators: M. Amor, P. Schneider, K. Snyder, L. Inglese

	08.15	State-of-the-art: promising next steps, K. Mathias
	08.30	What the data is telling us: the first 30 days need to be safer after any carotid repair, but how?, C. Setacci
	08.38	New stent designs: will they improve results? P. Schneider
	08.46	New access technologies, N. Cheshire
		Controversy
		08.54 Best medical therapy has improved: but how much, and will BMT be good enough to replace repair?, I. Van Herzeele
		08.59 Carotid endarterectomy remains the treatment of choice. The data prove it and stents cannot compete, A. Mansilha
		09.04 Discussion
	09.09	What is the optimal approach to asymptomatic carotid stenosis? Intervention or not? We cannot all be correct! A. Halliday
	09.17	Challenging case: the worst complication of the year. Can you help me problem solve? M. Amor
	09.25	Emergency management system: how to handle evolving stroke, K. Mathias
	09.33	Selection of stent and protection technique: which stent for which lesion, M. Amor
	09.41	Mechanical thrombectomy for acute stroke, K. Snyder
	09.52	Discussion

	10.00	Coffee break in the exhibition hall

	10.30	Results from the ROADSTER Trial and EU Experience, I. Van Herzeele
	10.38	CAS revival is now, P. Bergeron
	10.46	Get organized for in Hospital stroke (jatrogenic or not) acute rescue, L. Inglese
	10.54	Discussion
	11.00	How I see the future of CAS, F. Veith

11.15	Femoropopliteal disease - Part 2
	Moderators: Y. Gouëffic, K. Deloose, P. Schneider, C. Setacci

	TASC C/D femoropopliteal lesions
	11.15	Heparin bounded graft could challenge endovascular repair for TASC C-D lesions? R. Pulli
	11.23	Intra versus subintimal routes to treat femoropopliteal CTO lesions: techniques and results, F. Thaveau
	11.31	Endovascular treatment of occluded popliteal artery aneurysm, P. Veroux
	11.39	Discussion

	Managing complications
	11.45	How should we manage acute in-stent thrombosis during femoropopliteal recanalisation? Y. Gouëffic
	11.53	Recurring in-stent restenosis: what is the best management? E. Ducasse
	12.01	Acute popliteal endograft occlusion: frequency and management, E. Puras Mallagray
	12.09	Panel discussion

12.15	Moving toward Drug Eluting Solutions
	Moderator: M. Amor

	12.15	Clinical results Majestic trial, K. Keirse
	12.35	Experience of drug eluting technologies, M. Sibé

	13.00	Buffet lunch served on the rooftop, coffee served in the exhibition hall

14.00	The A-Z of A-I disease
	Moderators: R. McWilliams, I. Van Herzeele

	Access
	14.00	How I do PEVAR? – Video, Z. Rancic

	Imaging
	14.08	Overlay and dose reduction during aortic procedures, J. Constantinou

	AAA
	14.16	Will EVAS replace EVAR? I. Loftus
	14.24	EVAS and EVAR: What are the differences in case selection, deployment and surveillance? F. Torella
	14.32	Single sided access for EVAR: the future, M. Lachat
	14.40	Review of the literature on type II endoleaks, R. McWilliams
	14.48	Late endoleak management – case discussions – MCQ’s, J. Van Den Berg
	14.56	State of the art – How I do FEVAR? P. Kasprzak
	15.04	Troubleshooting after FEVAR, R. Vallabhaneni
	15.12	Iliac branched devices versus Iliac branched endoprothesis – differences in selection and usage, F. Verzini
	15.20	The lessons I have learned from RCT on RAAA management, F. Veith
	15.28	New evidences for hypogastric artery preservation during EVAR, E. Jean-Baptiste
	15.36	Tips and tricks for the CERAB technique, K. Deloose
	15.44	Is the endovascular world ready for 3D-printing and... vice versa? L. Maene
	15.50	Discussion

16.00	Associate Faculty and trainees program From start to excellency
	**Jury: N. Cheshire, P. Bergeron**
	Oral presentations in the auditorium
	**Jury: N. Mangialardi, E. Ducasse**
	ePosters presentations in the exhibition hall

	Oral presentations in the auditorium
	• Long-term performance of closed cell design self-expanding stainless steel stents in the treatment of Cockett’s Syndrome, Luis Loureiro
	• Loss of kidney function after endovascular treatment of peripheral arterial disease, Lars Bolt
	• Novel Innovative Endovascular Technique to salvage acute limb ischemia in Hostile Groin, Virendersingh Sheorain
	• Management of long Flush Superficial Femoral Artery Occlusions with Ipsilateral antegrade common femoral artery access, Amr Aborahma
	• Percutaneous imaging guided techniques of PV patency and integrity management - catheter directed local thrombolysis, stenting, endoluminal RFA & angioplasty or endoluminal RFA & stenting, Malkhaz Mizandari
	• Neurocognitive Functioning After Carotid Endarterectomy and Carotid Stenting With Filter Protection or Flow Reversal, Maarten Plessers
	• Mid-term outcome of hybrid revascularisation procedures for TASC C and D aorto-iliac and femoropopliteal disease, Vassilios Zymvragoudakis
	• What is the best Solution for In-Stent Restenosis after SFA Stenting: redo-PTA by use of POBA, Drugcoated balloons or Stent-Grafts, Koen Keirse
	• Adjunctive Procedures to lower risks of neurovascular complications in Thoracic Endovascular Aortic Repair: Experience in The Oxford Regional Vascular Unit, Francesca Fratesi
	• Thrombosis of femoral-popliteal graft treated with ultrasound assisted catheter – directed thrombolysis and stenting, Cinzia Moncalvo
	• Abdominal Aortic Aneurysm Repair Increases Cardiovascular Risk, Vimal Gokani
	• Does reintervention influence the late results of EVAR? Diletta Loschi
	• Early outcomes of patients transferred with ruptured suprarenal aneurysm or dissection: implications for the organisation of vascular services, Nung Rudarakanchana
	• OffRoad™ Re-entry Catheter System for Subintimal Recanalization of Chronic Total Occlusions in Femoropopliteal Arteries: Primary Safety and Efficacy Results of the Re-ROUTE Trial, Koen Keirse
	• Percutaneous recanalization of occluded renal arteries in patient with resistant hypertension and high rennin activity, Ivo Petrov
	• Vertebral stenting, Iveta Tasheva
	• Intervention for acute lower limb ischemia: a 3 year single center experience, Keisuke Fukuda
	• Ovation Prime Stent Graft System can be used for challenging anatomy in EVAR cases, Koen Keirse
	• Ovation Prime Stent Graft System can be used for challenging anatomy in EVAR cases, Koen Keirse
	• Three cases confirming the appropriateness of “centralization of flow concept” in aortic dissection, Ivo Petrov
	• Artificial intelligence algorithms to quantify arterial calcification, Ahmed Aber
	• Carotid Artery Stenting: is it possible to reduce complications? Cinzia Moncalvo
	• Endovascular Repair of Mycotic Thoracic Aneurysm, Baris Ozdemir
	• Is there a place for the bioprosthesis Omniflow II in the treatment of aortic graft infection? Sebastien Deglise
	• Overcoming Difficult CTO increasing the applicability of Endovascular Intervention to patients with challenging Re-entry, Ahmed Tawfik

	ePosters presentations in the exhibition hall
	• Carotid artery stenting with cerebral embolic protection: a single-center initial experience, Pablo Nuñez • Microcoil embolization for an acute bleed from ruptured middle rectal artery aneurysm, Vivek Vohra • Atherosclerotic plaque analysis in the lower limb may help predict outcome following endovascular intervention, Vassilios Zymvragoudakis • Use of drug-coated balloon angioplasty using the Invatec Admiral balloon as first line treatment for all femoropopliteal lesions: twelve month results, Koen Keirse • Percutaneus exclusion of sbclavian artery aneurysm with endoprosthesis, Cinzia Moncalvo • Revascularization of the plantar arch: its impact on foot salvage in critical limb ischemia, Mosaad Soliman • Interventional treatment of an intracranial left vertebral artery stenosis in the state of contralateral vertebral artery occlusion, Svetlin Tsonev • Percutaneous exclusion of renal artery aneurysm with endoprosthesis, Cinzia Moncalvo


17.30	Awards ceremony & adjournment


MEET Official dinner • Radisson BLU Hotel
Monday June 8, 20.00 till midnight • Limited seats

Participation fee: 60 € VAT incl. per person (buffet dinner)
Dress code: casual chic